JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M212520200 on February 14, 2003

J. Biol. Chem., Vol. 278, Issue 17, 15319-15325, April 25, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/17/15319    most recent
M212520200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoon, J.-B.
Right arrow Articles by Chun, J.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, J.-B.
Right arrow Articles by Chun, J.-S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Non-steroidal Anti-inflammatory Drugs Inhibit Nitric Oxide-induced Apoptosis and Dedifferentiation of Articular Chondrocytes Independent of Cyclooxygenase Activity*

Joo-Byoung YoonDagger , Song-Ja KimDagger , Sang-Gu HwangDagger , Sunghoe ChangDagger , Shin-Sung Kang§, and Jang-Soo ChunDagger ||

From the Dagger  Department of Life Science, Kwangju Institute of Science and Technology; Buk-Gu, Gwangju 500-712, Korea, and § Department of Biology, Kyungpook National University, Daegu 702-701, Korea

Nitric oxide (NO) causes apoptosis and dedifferentiation of articular chondrocytes by the modulation of extracellular signal-regulated kinase (ERK), p38 kinase, and protein kinase C (PKC) alpha  and -zeta . In this study, we investigated the effects and mechanisms of non-steroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, ketoprofen, ibuprofen, sulindac sulfide, and flurbiprofen, in NO-induced apoptosis and dedifferentiation of articular chondrocytes. We found that all of the examined NSAIDs inhibited apoptosis and dedifferentiation. NO production in chondrocytes caused activation of ERK-1/2 and p38 kinase, which oppositely regulate apoptosis and dedifferentiation. NO production also caused inhibition of PKCalpha and -zeta independent of and dependent on, respectively, p38 kinase, which is required for apoptosis and dedifferentiation. Among the signaling molecules modulated by NO, NSAIDs blocked NO-induced activation of p38 kinase, potentiated ERK activation, and blocked inhibition of PKCalpha and -zeta . NSAIDs also inhibited some of the apoptotic signaling that is downstream of p38 kinase and PKC, such as NFkappa B activation, p53 accumulation, and caspase-3 activation. The inhibitory effects of NSAIDs on apoptosis and dedifferentiation were independent of the inhibition of cyclooxygenase (COX)-2 and prostaglandin E2 (PGE2) production, as evidenced by the observation that specific inhibition of COX-2 activity and PGE2 production or exogenous PGE2 did not affect NO-induced apoptosis and dedifferentiation. Taken together, our results indicate that NSAIDs block NO-induced apoptosis and dedifferentiation of articular chondrocytes by the modulation of ERK, p38 kinase, and PKCalpha and -zeta in a manner independent of their ability to inhibit COX-2 and PGE2 production.


* This work was supported by the National Research Laboratory Program (M1-0104-00-0064) from the Korea Ministry of Science and Technology and the Interdisciplinary Research Project (1999-2-207-004-5) from the Korea Science and Engineering Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Funded by Korea Research Foundation Grant KRF-2000-015-DP0352.

|| To whom correspondence should be addressed. Tel.: 82-62-970-2497; Fax: 82-62-970-2484; E-mail: jschun@kjist.ac.kr.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
M M Conradie, H de Wet, D D R Kotze, J M Burrin, F S Hough, and P A Hulley
Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo
J. Endocrinol., November 1, 2007; 195(2): 229 - 240.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Boileau, J Martel-Pelletier, J Brunet, D Schrier, C Flory, M Boily, and J-P Pelletier
PD-0200347, an {alpha}2{delta} ligand of the voltage gated calcium channel, inhibits in vivo activation of the Erk1/2 pathway in osteoarthritic chondrocytes: a PKC{alpha} dependent effect
Ann Rheum Dis, May 1, 2006; 65(5): 573 - 580.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Boileau, J-P Pelletier, G Tardif, H Fahmi, S Laufer, M Lavigne, and J Martel-Pelletier
The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway
Ann Rheum Dis, June 1, 2005; 64(6): 891 - 898.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
S. Ozgocmen, O. Ardicoglu, H. Erdogan, E. Fadillioglu, and H. Gudul
In Vivo Effect of Celecoxib and Tenoxicam on Oxidant/Anti-oxidant Status of Patients with Knee Osteoarthritis
Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-G. Hwang, S.-S. Yu, J.-H. Ryu, H.-B. Jeon, Y.-J. Yoo, S.-H. Eom, and J.-S. Chun
Regulation of {beta}-Catenin Signaling and Maintenance of Chondrocyte Differentiation by Ubiquitin-independent Proteasomal Degradation of {alpha}-Catenin
J. Biol. Chem., April 1, 2005; 280(13): 12758 - 12765.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-G. Hwang, J.-H. Ryu, I.-C. Kim, E.-H. Jho, H.-C. Jung, K. Kim, S.-J. Kim, and J.-S. Chun
Wnt-7a Causes Loss of Differentiated Phenotype and Inhibits Apoptosis of Articular Chondrocytes via Different Mechanisms
J. Biol. Chem., June 18, 2004; 279(25): 26597 - 26604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Kim, S.-G. Hwang, I.-C. Kim, and J.-S. Chun
Actin Cytoskeletal Architecture Regulates Nitric Oxide-induced Apoptosis, Dedifferentiation, and Cyclooxygenase-2 Expression in Articular Chondrocytes via Mitogen-activated Protein Kinase and Protein Kinase C Pathways
J. Biol. Chem., October 24, 2003; 278(43): 42448 - 42456.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-D. Oh and J.-S. Chun
Signaling Mechanisms Leading to the Regulation of Differentiation and Apoptosis of Articular Chondrocytes by Insulin-like Growth Factor-1
J. Biol. Chem., September 19, 2003; 278(38): 36563 - 36571.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.